EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Dengue Vaccine Effectiveness: Results from a 6-Year Population-Based Cohort Study in Southern Brazil

Karin Regina Luhm, Silvia Emiko Shimakura, Sonia Mara Raboni, Magda Clara Vieira da Costa-Ribeiro, Fredi Alexander Diaz-Quijano, Angela Maron de Mello, Lineu Silva, Marilene da Cruz Magalhães Buffon, Eliane Mara Cesario Pereira Maluf, Gabriel Graeff, Clara Preto, Gustavo Almeida und 4 weitere

The American Journal of Tropical Medicine and Hygiene · 04.02.2026 · 114 (2) · 338-347

DOI: 10.4269/ajtmh.24-0837 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, erschienen am 04.02.2026. Verfasst von Karin Regina Luhm und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Federal University of Paraná, Curitiba, Brazil. Hauptthemen laut MEDLINE: Dengue Vaccines, Dengue, Vaccine Efficacy, Dengue Virus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The alarming growth of dengue worldwide, as well as its social and economic impact, has necessitated effective responses for its control. Brazil, the second country to use Dengvaxia ® (Sanofi Pasteur, Paris, France) after the Philippines, has offered the vaccine to ∼500,000 residents in 30 municipalities, with ∼300,000 being vaccinated. In this population-based cohort study, the vaccine’s effectiveness (VE) is reported after a 6-year follow-up for a vaccination campaign. The primary outcome was probable dengue case (PDC). Laboratory-confirmed dengue, serotype, warning signs, and hospitalization were considered secondary endpoints. Approximately 60% of participants received at least one vaccine dose. A total of 50,658 PDCs were identified, of which 15,131 were laboratory-confirmed dengue cases. Overall, the VE was 34% (95% CI: 33% to 35%) for PDCs and 20% (95% CI: 17% to 23%) for laboratory-confirmed cases. Greater VE was observed in older individuals. Vaccination was effective in reducing dengue virus (DENV)-1 and DENV-4 cases but not DENV-2 cases. No DENV-3 cases were registered. Among the 1,129 hospitalizations, 619 (54.8%) occurred within the vaccinated population, including 16 severe cases, whereas 510 (45.2%) hospitalizations occurred within the non-vaccinated population, with 18 severe cases. The VE for PDC hospitalizations was 16.5% (95% CI: 5.5% to 26.3%). Five and nine dengue-related deaths occurred within the vaccinated and non-vaccinated populations, respectively. The low incidence of severe cases and warning signs compromised accuracy. Vaccination with at least one dose was associated with approximately a one-third reduction in PDC incidence and a significant reduction in DENV-1 and DENV-4 cases. Despite the VE falling below 50%, vaccination may be justifiable in regions with high disease burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dengue VaccinesDengueVaccine EfficacyDengue VirusHumansBrazilFemaleCohort StudiesMaleChildChild, PreschoolAdultAdolescentMiddle AgedYoung AdultInfantHospitalizationVaccinationAged

Substanzen

Dengue Vaccines

Autor:innen und Institutionen

  • Department of Public Health, Federal University of Paraná, Curitiba, Brazil.
  • Postgraduate Program in Public Health, Federal University of Paraná, Curitiba, Brazil.
  • Department of Statistics, Federal University of Paraná, Curitiba, Brazil.
  • Department of Basic Pathology and Postgraduate Program in Microbiology, Parasitology and Pathology, Federal University of Paraná, Curitiba, Brazil.
  • Department of Epidemiology, Laboratory of Causal Inference in Epidemiology - LINCE-USP, School of Public Health, University of São Paulo, São Paulo, Brazil.
  • Health Ministry, Curitiba, Brazil.

Zitieren

APA

Luhm, K. R., Shimakura, S. E., Raboni, S. M., Costa-Ribeiro, M. C. V. D., Diaz-Quijano, F. A., Maron de Mello, A., Silva, L., Buffon, M. D. C. M., Maluf, E. M. C. P., Graeff, G., Preto, C., Almeida, G., Sousa, G. A., Krainski, E. T., Evans, A. A., & Carvalho, D. S. (2026). Dengue Vaccine Effectiveness: Results from a 6-Year Population-Based Cohort Study in Southern Brazil. The American Journal of Tropical Medicine and Hygiene, 114(2), 338-347. https://doi.org/10.4269/ajtmh.24-0837

Vancouver

Luhm KR, Shimakura SE, Raboni SM, Costa-Ribeiro MCVD, Diaz-Quijano FA, Maron de Mello A, et al. Dengue Vaccine Effectiveness: Results from a 6-Year Population-Based Cohort Study in Southern Brazil. The American Journal of Tropical Medicine and Hygiene. 2026;114(2):338-347. doi:10.4269/ajtmh.24-0837

BibTeX
@article{Luhm2026,
  author = {Luhm, Karin Regina and Shimakura, Silvia Emiko and Raboni, Sonia Mara and Costa-Ribeiro, Magda Clara Vieira da and Diaz-Quijano, Fredi Alexander and Maron de Mello, Angela and Silva, Lineu and Buffon, Marilene da Cruz Magalhães and Maluf, Eliane Mara Cesario Pereira and Graeff, Gabriel and Preto, Clara and Almeida, Gustavo and Sousa, Gabriela Amanda de and Krainski, Elias Teixeira and Evans, Allan Arnold and Carvalho, Denise Siqueira de},
  title = {Dengue Vaccine Effectiveness: Results from a 6-Year Population-Based Cohort Study in Southern Brazil},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2026},
  volume = {114},
  number = {2},
  pages = {338--347},
  doi = {10.4269/ajtmh.24-0837}
}
Kostenlos starten →